Valuation : EMV Capital plc

Market Cap 13.56M 18.37M 15.8M 14.86M 25.37M 1.74B 25.45M 176M 68.1M 890M 68.99M 67.48M 2.83B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 12.54M 16.98M 14.6M 13.73M 23.44M 1.61B 23.52M 163M 62.94M 822M 63.76M 62.36M 2.62B EV / Sales 2026 *
3.66x
EV / Sales 2027 * 3.68x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 day-2.37%
1 week-6.24%
Current month-6.24%
1 month-11.50%
3 months-2.37%
6 months-17.65%
Current year-16.93%
1 week 47
Extreme 47
52
1 month 47
Extreme 47
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 2020-04-30
Director of Finance/CFO 45 2025-11-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 2019-10-13
Director/Board Member 47 2022-12-08
Chairman 61 2023-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
1/8/26 Buy 7,000 0.0250%
1/8/26 Sell 7,000 0.0250%
12/19/25 Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
-2.37%-6.24%+12.74%-23.01% 18.37M
-0.55%-2.70%+60.00%+31.07% 3.7B
+0.31%+0.08%-9.07%+10.74% 3.25B
+1.72%+0.21%+34.86%+28.54% 1.9B
+0.22%+0.52%+84.89%+183.40% 1.47B
0.00%0.00%-1.72%-7.02% 730M
+3.16%+0.51%+157.05%+211.73% 600M
+2.07%+2.07%-1.33%-5.13% 410M
0.00%0.00%-38.60%-75.18% 391M
0.00%0.00%-0.53%-13.02% 371M
Average +0.41%-0.34%+29.83%+34.21% 1.28B
Weighted average by Cap. +0.35%-0.81%+35.86%+43.49%

Financials

2026 *2027 *
Net sales 3.43M 4.64M 3.99M 3.76M 6.41M 439M 6.43M 44.54M 17.22M 225M 17.44M 17.06M 717M 3.75M 5.08M 4.37M 4.11M 7.02M 481M 7.04M 48.74M 18.84M 246M 19.08M 18.67M 784M
Net income - -
Net Debt -1.03M -1.39M -1.2M -1.13M -1.92M -132M -1.93M -13.36M -5.17M -67.48M -5.23M -5.12M -215M 233K 315K 271K 255K 435K 29.82M 437K 3.02M 1.17M 15.27M 1.18M 1.16M 48.63M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
26-09-08 GBX 47.35 -2.37% 6,119
26-09-07 GBX 48.50 0.00% 9,603
26-09-04 GBX 48.50 -3.96% 16,206
26-09-03 GBX 50.50 0.00% 5,552
26-09-02 GBX 50.50 0.00% 1,323
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4850GBP
Average target price
1.320GBP
Spread / Average Target
+172.16%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!